Related Experiment Video
Updated: Feb 5, 2026

Radiosensitivity of Cancer Stem Cells in Lung Cancer Cell Lines
Published on: August 21, 2019
Low Dose Naltrexone and Lung Cancer: A Case Report and Discussion
Jeffrey A Miskoff1, Moiuz Chaudhri1
1Medicine, Jersey Shore University Medical Center, Neptune City, USA.
Abstract:
Low dose naltrexone (LDN) has been promising as a complementary medication for patients with a broad range of medical disorders. Although not a proven cure, evidence from clinical trials supports LDN as being a valuable adjunct for disorders in which the immune system plays a centralized role. Additionally, clinical trials have proposed a unique mechanism(s) allowing LDN to affect tumors including non-small cell lung cancer (NSCLC) at the cellular level by augmenting the immune system. We present a case of a 50-year-old male with a prolonged survival and a past medical history of prostate and lung cancer.
Related Concept Videos
Lung Capacity
Dose Size and Dosing Frequency: Determination Methods
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
Data Reporting and Recording
Rational Dosage Regimen: Maintenance Dose and Loading Dose
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
Types of Reports I: Hands-off Report
Following are the key components and categories of hand-off reports:
Purpose and Process:

